Showing 1 - 20 results of 22 for search 'P. Musto', query time: 0.04s
Refine Results
-
1
-
2
-
3
P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) by N. Sgherza, P. Curci, R. Rizzi, D. Roccotelli, M. Croce, M. Avantaggiato, L. Ruga, A. Vitucci, A. Palma, D. Di Gennaro, P. Musto
Published 2022-06-01
Article -
4
PB2156: ANALYSIS OF POSSIBLE CLONAL ORIGIN OF LARGE B-CELL DIFFUSED LYMPHOMAS ARISING IN PATIENTS WITH PRE-EXISTING HODGKIN’S LYMPHOMA by P. Masciopinto, E. Bellitti, G. Opinto, E. Arcuti, L. Mastracci, S. Ciavarella, G. Cazzato, A. Guarini, E. Maiorano, P. Musto, G. Ingravallo, F. Gaudio
Published 2022-06-01
Article -
5
P1598: SARS-COV2 INFECTION IN FULLY VACCINATED PATIENTS WITH LYMPHOID MALIGNANCIES DURING THE “THIRD WAVE”: A SINGLE-CENTER EXPERIENCE OF 57 PATIENTS. by V. Strafella, T. Perrone, P. Masciopinto, A. Giordano, F. Gaudio, M. C. Longo, O. Battisti, E. Arcuti, L. Strippoli, G. Brindicci, A. Saracino, P. Stefanizzi, S. Tafuri, F. Albano, P. Musto
Published 2022-06-01
Article -
6
P664: GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLL. by S. Molica, C. Patti, P. Sportoletti, A. Chiarenza, A. M. Giordano, F. Chiurazzi, N. Di Renzo, P. Musto, F. Pane, F. Di Raimondo, L. Trentin, F. R. Mauro, D. Giannarelli
Published 2022-06-01
Article -
7
S244: EFFECT OF ANTI-SPIKE NEUTRALIZING MONOCLONAL ANTIBODIES ON COVID-19 PROGRESSION AND TIME TO VIRAL CLEARANCE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND SARS-COV-2 INFECTI... by V. Marasco, A. Guidetti, A. Piciocchi, A. Candoni, M. Bocchia, R. Bruna, P. Musto, A. Visentin, M. Turrini, A. Tucci, C. Selleri, E. Crea, P. Fazi, F. Passamonti, P. Corradini
Published 2022-06-01
Article -
8
P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC by P. Musto, J. Salmanton-García, N. Sgherza, R. Bergantim, F. Farina, A. Glenthøj, G.C. Seval, B. Weinbergerová, V. Bonuomo, Y.M. Bilgin, L. Rahimli, F. Marchesi, O.A. Cornely, L. Pagano
Published 2023-05-01
Article -
9
P1319: T AND B LYMPHOCYTES SUBSETS AFTER BNT162B2 ANTI-SARS-COV-2 M-RNA VACCINATION: A COMPARISON BETWEEN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS AND HEALTHY CONTROLS. by I. Attolico, F. Tarantini, C. P. Schifone, A. Mestice, G. De Tullio, C. Derosa, F. Carbone, A. Negri, P. Carluccio, M. Delia, F. Albano, A. M. V. Larocca, P. Stefanizzi, L. Vimercati, S. Tafuri, P. Musto
Published 2022-06-01
Article -
10
P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN M... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published 2022-04-01
Article -
11
P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MUL... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published 2022-04-01
Article -
12
PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK? by C. Cumbo, F. Tarantini, A. Zagaria, L. Anelli, C. F. Minervini, N. Coccaro, G. Tota, L. Impera, E. Parciante, M. R. Conserva, I. Redavid, P. Carluccio, M. Delia, A. Giordano, C. Longo, T. Perrone, A. Russo Rossi, G. Specchia, P. Musto, F. Albano
Published 2022-06-01
Article -
13
P564: FINAL RESULTS OF THE QOLESS AZA-AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5-AZA FOR POST-REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS by E. N. Oliva, P. Salutari, F. Di Raimondo, G. Reda, D. Capelli, G. Iannì, G. Tripepi, C. Alati, C. Mammì, M. G. D’Errigo, P. Niscola, C. Selleri, P. Musto, E. Vigna, A. Volpe, N. Cascavilla, M. C. Cannatà, D. Mannina, A. Candoni
Published 2022-06-01
Article -
14
PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) by A. Mele, E. Prete, S. Citiso, G. Mele, D. Pastore, N. Sgherza, P. Curci, P. Musto, A. P. Falcone, N. Cascavilla, C. Germano, T. Giuseppe, G. Reddiconto, N. Di Renzo, G. Palazzo, P. Mazza, B. Rossini, A. Guarini, G. Palumbo, L. M. A. Melillo, V. Pavone
Published 2022-06-01
Article -
15
P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38... by M. Offidani, S. Morè, M. Cavo, D. Derudas, F. Di Raimondo, A. Cuneo, L. Baldini, R. Della Pepa, M. Musso, M. Boccadoro, P. Musto, A. Belotti, F. Fioritoni, N. Di Renzo, A. Mele, B. Gamberi, L. De Paoli, R. Zambello, S. Grammatico, M. Brociner, F. Fazio, M. T. Petrucci
Published 2023-05-01
Article -
16
B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM by D. Hofste op Bruinink, R. Kuiper, M. van Duin, T. Cupedo, V. van der Velden, R. Hoogenboezem, B. van der Holt, B. Beverloo, E. Valent, M. Vermeulen, M. D’Agostino, F. Gay, A. Broijl, H. Avet-Loiseau, N. Munshi, P. Musto, P. Moreau, S. Zweegman, N. van de Donk, P. Sonneveld
Published 2023-05-01
Article -
17
P1084: CHECK-POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFRACTORY HODGKIN’S LYMPHOMA: A RETROSPECTIVE ANALYSYS BY THE RETE EMATOLOGICA PUGLIESE (REP). by F. Gaudio, G. Loseto, V. Bozzoli, P. R. Scalzulli, A. M. Mazzone, L. Tonialini, V. Fesce, G. Quintana, G. De santis, P. Masciopinto, E. Arcuti, F. Clemente, S. Scardino, G. Tarantini, D. Pastore, L. Melillo, V. Pavone, P. Mazza, A. M. Carella, N. Cascavilla, N. Di Renzo, A. Guarini, P. Musto
Published 2022-06-01
Article -
18
B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS by P. Musto, M.C. Minnema, W.W.H. Roeloffzen, A. Capra, B. van der Holt, A. Juul Vangsted, A. Broyl, F. Schjesvold, T. Lund, T. Silkjaer, R. Benjamin, M. Grasso, K. Lung Wu, J. Caers, M. Cavo, R. Hájek, B. Bruno, A. Gadisseur, G. Pietrantuono, M. Offidani, L. Pour, P. Sonneveld, M. Boccadoro, N. van de Donk
Published 2023-05-01
Article -
19
B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR... by N. van de Donk, M.C. Minnema, B. van der Holt, F. Schjesvold, K.L. Wu, A. Capra, A. Broyl, W.W.H. Roeloffzen, A.P.A. Gadisseur, G. Pietrantuono, L. Pour, V. van der Velden, T. Lund, M. Offidani, M. Grasso, L. Giaccone, M. Cavo, T. Silkjaer, J. Caers, S. Zweegman, R. Hajek, R. Benjamin, A. Vangsted, M. Boccadoro, F. Gay, P. Sonneveld, P. Musto
Published 2023-05-01
Article -
20
P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE... by E. A. Martino, C. Conticello, E. Zamagni, V. Pavone, S. Palmieri, M. Musso, P. Tacchetti, A. Mele, L. Catlano, E. Vigna, A. Bruzzese, F. Mendicino, C. Botta, D. Vincelli, G. Farina, M. Barone, C. Cangialosi, K. Mancuso, I. Rizziello, S. Rocchi, A. P. Falcone, G. Mele, G. Reddiconto, B. Garibaldi, E. Iaccino, G. Tripepi, F. Di Raimondo, P. Musto, A. Neri, M. Cavo, F. Morabito, M. Gentile
Published 2022-06-01
Article